Back
Replimune Group, Inc. REPL · Transcripts
website
Replimune Group, Inc. is a biotechnology enterprise dedicated to pioneering oncolytic immuno-gene th...465
Price22.2716
Market Cap2.05 B
Float89.16 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents